share_log

Needham Reiterates Buy on Cogent Biosciences, Maintains $18 Price Target

Moomoo 24/7 ·  Feb 26 04:59

Needham analyst Ami Fadia reiterates Cogent Biosciences (NASDAQ:COGT) with a Buy and maintains $18 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment